Ticker: CPHI, Company: CHINA PHARMA HOLDINGS, INC., Type: 10-K, Date: 2010-03-04
Original SEC Filing: Click here

---

Webplus: CPHI/20100304/10-K/1/000.htm SEC Original: cph10k123109.htm
Form 10-K (Mark one) x For the fiscal year ended: December 31, 2009 o For the transition period from ______________ to _____________ China Pharmas, Delaware 73-1564807 (State or other jurisdiction (I.R.S. Employer I.D. No.)orporation or organization) 2nd Floor, No. 17, Jinpan Road, Haikou, Hainan Province, China 570216 0086-898-66811730 (China)

---

---

Webplus: CPHI/20100304/10-K/2_EX-10.18/000.htm SEC Original: cph10kex1018123109.htm
Anhui Fuyang Xinte Pharmaceuticalmpany , Sesntract Name of Product Quality standard andecification Unit Unit price Quantity Amount(RMB) Tiopronin 1200.00 1000 1200000 Hepatocyte growthpromoting factor 9000.00 40 3600000 Micro-fiber products 33.00 8000 264000 Medicinal Starch 4.6 5000 23000 Pre-gel starch 8.5 4000 34000 Total amount Five million one hundred and twenty one thousand only

---

---

Webplus: CPHI/20100304/10-K/3_EX-10.19/000.htm SEC Original: cph10kex1019123109.htm
Raw Material Purchase /lesntractte signed : 2009-03-25 Place: Haikou Accordingly to friendly negotiation, both Partiesree to the term andndition stated following, 1 Name,ecification, quantity and total amount of product Name of Product Quality standard andecification Unit Unit price Quantity Amount(RMB) Brain tissue initial liquid

---

---

Webplus: CPHI/20100304/10-K/4_EX-10.20/000.htm SEC Original: cph10kex1020123109.htm
Sale sntract of Helpson Medical & Biotechnology C ontract No. Signed at: Arrival port: C ustom No.: B usiness No.: According to the related stipulation of “People’s Republic of China Law ofntract”, afternsulting unanimously, both sides sign thisntract: NO. Name ofmmodity ,Specifications Unit Quantity

---

---

Webplus: CPHI/20100304/10-K/5_EX-10.21/000.htm SEC Original: cph10kex1021123109.htm
Sale sntract of Helpson Medical & Biotechnology C ontract No. Signed at: Arrival port: C ustom No. : B usiness No. : According to the related stipulation of “People’s Republic of China Law ofntract”, afternsulting unanimously, both sides sign thisntract: NO. Name ofmmodity,ecifications

---

---

Webplus: CPHI/20100304/10-K/6_EX-31.1/000.htm SEC Original: cph10kex311123109.htm
CERTIFICATION OF CHIEF EXECUTIVE OFFICER OF THERBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 2)Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not

---

---

Webplus: CPHI/20100304/10-K/7_EX-31.2/000.htm SEC Original: cph10kex312123109.htm
CERTIFICATION OF CHIEF FINANC IAL OFFICER OF THERBANES-OXLEY ACT OF 2002 I, Frank Waung, certify that: Frank Waung Chief Financial Officer cph10kex312123109.htm 7 EX-31.2

---

---

Webplus: CPHI/20100304/10-K/8_EX-32.1/000.htm SEC Original: cph10kex321123109.htm
CERTIFICATION OF CHIEF EXECUTIVE OFFICER 18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 Zhilin Li Chief Executive Officer cph10kex321123109.htm 8 EX-32.1

---

---

Webplus: CPHI/20100304/10-K/9_EX-32.2/000.htm SEC Original: cph10kex322123109.htm
CERTIFICATION OF CHIEF FINANCIAL OFFICER 18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 Frank Waung Chief Financial Officer cph10kex322123109.htm 9 EX-32.2

---

Company Information:

Ticker: CPHI, Company: CHINA PHARMA HOLDINGS, INC., Type: 10-K, Date: 2010-03-04CIK: 0001106644, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
2ND FLOOR, NO. 17, JINPAN ROAD, HAIKOU
HAINAN PROVINCE 570216